1. Anturan for secondary prophylaxis of myocardial infarction.
- Author
-
Bokarev IN, Lusov VA, Golikov AP, Ptushkin VV, Zvereva TV, Savenkov MP, and Seregina MV
- Subjects
- Adrenergic beta-Antagonists administration & dosage, Adrenergic beta-Antagonists therapeutic use, Diuretics administration & dosage, Diuretics therapeutic use, Drug Therapy, Combination, Female, Glucosides administration & dosage, Glucosides therapeutic use, Humans, Male, Middle Aged, Myocardial Infarction mortality, Sulfinpyrazone administration & dosage, Myocardial Infarction prevention & control, Sulfinpyrazone therapeutic use
- Abstract
273 patients suffering from ischemic heart disease were treated with Anturan for one year at a daily dosage of 800 mg. The number of cardiovascular complications was significantly reduced, compared to the control group.
- Published
- 1988